STOCK TITAN

Insulet Set to Join S&P 500

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

NEW YORK, March 10, 2023 /PRNewswire/ -- Insulet Corp. (NASD:PODD) will replace SVB Financial Group (NASD:SIVB) in the S&P 500 effective prior to the opening of trading on Wednesday, March 15. The Federal Deposit Insurance Corporation (FDIC) announced that it has taken SVB Financial Group into FDIC Receivership and therefore SVB Financial Group is no longer eligible for inclusion.    

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date

Index Name      

Action

Company Name

Ticker

GICS Sector

March 15, 2023

S&P 500

Addition

Insulet

PODD

Health Care


S&P 500

Deletion

SVB Financial Group

SIVB

Financials

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indices
index_services@spglobal.com

Media Inquiries
spdji.comms@spglobal.com

Cision View original content:https://www.prnewswire.com/news-releases/insulet-set-to-join-sp-500-301769457.html

SOURCE S&P Dow Jones Indices

Insulet Corporation

NASDAQ:PODD

PODD Rankings

PODD Latest News

PODD Stock Data

12.14B
69.53M
0.31%
103.67%
4.46%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ACTON

About PODD

insulet corporation is an innovative medical device company based in billerica, massachusetts. it was founded in 2000 with the mission of improving the lives of people with diabetes. specifically, through its revolutionary omnipod insulin management system, insulet seeks to expand the use of insulin pump therapy. studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (mdi); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. despite these benefits, most people still choose mdi therapy largely due to the complexity, cost and inconvenience of conventional pump technology. the omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. improvements include omnipod's lack of tubing; automated, virtually pain-free insertion; and two straightforward parts that communicate wirelessly. by breaking down